Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans

Experimental and Clinical Psychopharmacology

Volumn 14, Issue 2, 2006, Pages 136-147

  Lile, Joshua A ^a   Stoops, William W ^a,b   Durell, Todd M ^a,c   Glaser, Paul E A ^a   Rush, Craig R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Agonist replacement therapy; Atomoxetine; Drug discrimination; Methylphenidate; Subjective effects

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE; PLACEBO; TRIAZOLAM;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR FUNCTION; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ABUSE; DRUG DISCRIMINATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTPATIENT; PERFORMANCE; PSYCHOMOTOR ACTIVITY; QUESTIONNAIRE; SELF REPORT; TASK PERFORMANCE;

ADOLESCENT; ADULT; BLOOD PRESSURE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MALE; METHYLPHENIDATE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROPYLAMINES;

EID: 33745634621     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.14.2.136     Document Type: Article

References (61)

1. Abreu, M. E., & Griffiths, R. R. (1996). Drug tasting may confound human drug discrimination studies. Psychopharmacology, 125, 255-257.
2. Baker, L. E., Riddle, E. E., Saunders, R. B., & Appel, J. B. (1993). The role of monoamine uptake in the discriminative-stimulus effects of cocaine and related compounds. Behavioral Pharmacology, 4, 69-79.
3. Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K., Threlkeld, P. G., Heiligenstein, J. H., et al. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology, 27, 699-711.
4. Callahan, P. M., de la Garza, R., & Cunningham, K. A. (1997). Mediation of the discriminative-stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacology, Biochemistry and Behavior, 57, 601-607.
5. Campbell, J., Nickel, E. J., Penick, E. C., Wallace, D., Gabrielli, W. F., Rowe, C., et al. (2003). Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients. American Journal of Addiction, 12, 122-136.
6. Carboni, E., Tanda, G. L., Frau, R., & Di Chiara, G. (1990). Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals. Journal of Neurochemistry, 55, 1067-1070.
7. Cunningham, K. A., & Callahan, P. M. (1991). Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology, 104, 177-180.
8. Czoty, P. W., Ramanathan, C. R., Mutschler, N. H., Makriyannis, A., & Bergman, J. (2004). Drug discrimination in methamphetamine-trained monkeys: Effects of monoamine transporter inhibitors. Journal of Pharmacology and Experimental Therapeutics, 311, 720-727.
9. Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology, 30, 205-211.
10. de la Garza, R., & Johanson, C. E. (1987). Discriminative-stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 243, 955-962.
11. Devoto, P., Flore, G., Saba, P., Fa, M., & Gessa, G. L. (2005). Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. Journal of Neurochemistry, 92, 368-374.
12. Di Marino, M. E., Haberny, K. A., Felch, L. J., Walsh, S. L., Preston, K. L., & Bigelow, G. E. (1998). Development of a subjective rating scale sensitive to acute cocaine administration. National Institute on Drug Abuse Research Monograph Series, Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Scientific Meeting, 178, 139.
13. Evans, S. M., & Johanson, C. E. (1987). Amphetamine-like effects of anorectics and related compounds in pigeons. Journal of Pharmacology and Experimental Therapeutics, 241, 817-825.
14. Fant, R. V., Owen, L. E., & Henningfield, J. E. (1999). Nicotine replacement therapy. Primary Care, 26, 633-652.
15. Gasior, M., Bergman, J., Kallman, M. J., & Paronis, C. A. (2005). Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology, 30, 758-764.
16. Gonzalez, G., Oliveto, A., & Kosten, T. R. (2004). Combating opiate dependence: A comparison among the available pharmacological options. Expert Opinion on Pharmacotherapy, 5, 713-725.
17. Gorelick, D. A., Gardner, E. L., & Xi, Z. X. (2004). Agents in development for the management of cocaine abuse. Drugs, 64, 1547-1573.
18. Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001). Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial. Journal of Clinical Psychopharmacology, 21, 522-526.
19. Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., et al. (2004). Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: Two double-blind randomized clinical trials. Neuropsychopharmacology, 29, 969-981.
20. Heil, S. H., Holmes, H. W., Bickel, W. K., Higgins, S. T., Badger, G. J., Laws, H. F., & Faries, D. E. (2002). Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug and Alcohol Dependence, 67, 149-156.
21. Hughes, J. R., Shiffman, S., Callas, P., & Zhang, J. (2003). A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tobacco Control, 12, 21-27.
22. Jasinski, D. R. (1977). Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In W. R. Martin (Ed.), Handbook of experimental pharmacology (pp. 197-258). Berlin, Germany: Springer.
23. Jasinski, D. R., Fariesb, D., & Allen, A. J. (2004). Abuse liability assessment of atomoxetine in a drug-abusing population. International Journal of Neuropsychopharmacology, 7(Suppl. 1), S310.
24. Johanson, C. E., & Barrett, J. E. (1993). The discriminative-stimulus effects of cocaine in pigeons. Journal of Pharmacology and Experimental Therapeutics, 267, 1-8.
25. Karnath, B. (2002). Smoking cessation. American Journal of Medicine, 112, 399-405.
26. Kelly, T. H., Stoops, W. W., Perry, A. S., Prendergast, M. A., & Rush, C. R. (2003). Clinical neuropharmacology of drugs of abuse: A comparison of drug-discrimination and subject-report measures. Behavioral Cognitive Neuroscience Reviews, 2, 227-260.
27. Kleven, M. S., Anthony, E. W., & Woolverton, W. L. (1990). Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 254, 312-317.
28. Kleven, M. S., & Koek, W. (1998). Discriminative-stimulus properties of cocaine: Enhancement by monoamine reuptake blockers. Journal of Pharmacology and Experimental Therapeutics, 284, 1015-1024.
29. Kosten, T., Oliveto, A., Feingold, A., Poling, J., Sevarino, K., McCance-Katz, E., et al. (2003). Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug and Alcohol Dependence, 70, 315-325.
30. Kreek, M. J. (2000). Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences, 909, 186-216.
31. Kuczenski, R., & Segal, D. S. (1997). Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. Journal of Neurochemistry, 68, 2032-2037.
32. Lamb, R. J., & Henningfield, J. E. (1994). Human d-amphetamine drug discrimination: Methamphetamine and hydromorphone. Journal of the Experimental Analysis of Behavior, 61, 169-180.
33. Lategan, A. J., Marien, M. R., & Colpaert, F. C. (1990). Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Research, 523, 134-138.
34. Levin, F. R., & Lehman, A. F. (1991). Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. Journal of Clinical Psychopharmacology, 11, 374-378.
35. Lile, J. A., & Nader, M. A. (2003). The abuse liability and therapeutic potential of drugs evaluated for cocaine addiction as predicted by animal models. Current Neuropharmacology, 1, 21-46.
36. Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245-258.
37. McLeod, D. R., Griffiths, R. R., Bigelow, G. E., & Yingling, J. E. (1982). An automated version of the Digit Symbol Substitution Test (DSST). Behavioral Research Methods and Instruments, 14, 463-466.
38. Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., et al. (2003). Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biological Psychiatry, 53, 112-120.
39. Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., et al. (2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896-1901.
40. Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., & Spencer, T. (2001). Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics, 108, E83.
41. Middaugh, L. D., McGroarty, K. K., Groseclose, C. H., & Adinoff, B. (1998). Cocaine discrimination: Relation to local anesthetics and monoamine reuptake inhibitors in C57BL/6 mice. Psychopharmacology, 136, 44-49.
42. Moghaddam, B., & Bunney, B. S. (1989). Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: Comparison to amphetamine. Synapse, 4, 156-161.
43. Munzar, P., & Goldberg, S. R. (1999). Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology, 143, 293-301.
44. Oliveto, A. H., Bickel, W. K., Hughes, J. R., Shea, P. J., Higgins, S. T., & Fenwick, J. W. (1992). Caffeine drug discrimination in humans: Acquisition, specifications, and correlation with self-reports. Journal of Pharmacology and Experimental Therapeutics, 261, 885-894.
45. Oliveto, A. H., McCance-Katz, E., Singha, A., Hameedi, F., & Kosten, T. R. (1998). Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behavioral Pharmacology, 9, 207-217.
46. Oliveto, A. H., Rosen, M. I., Woods, S. W., & Kosten, T. R. (1995). Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. Journal of Pharmacology and Experimental Therapeutics, 272, 231-241.
47. PDR staff. (2004). Physicians' desk reference. Oradell, NJ: Medical Economics.
48. Rush, C. R., & Baker, R. W. (2001). Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Experimental and Clinical Psychopharmacology, 9, 59-73.
49. Rush, C. R., Kelly, T. H., Hays, L. R., & Wooten, A. F. (2002). Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug and Alcohol Dependence, 67, 311-322.
50. Rush, C. R., Kollins, S. H., & Pazzaglia, P. J. (1998). Discriminative-stimulus and subject-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine trained humans. Experimental and Clinical Psychopharmacology, 6, 32-44.
51. Rush, C. R., Stoops, W. W., Hays, L. R., Glaser, P. E. A., & Hays, L. S. (2003). Risperidone attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine. Journal of Pharmacology and Experimental Therapeutics, 306, 195-204.
52. Sasaki, J. E., Tatham, T. A., & Barrett, J. E. (1995). The discriminative-stimulus effects of methamphetamine in pigeons. Psychopharmacology, 120, 303-310.
53. Shearer, J., Wodak, A., van Beek, I., Mattick, R. P., & Lewis, J. (2003). Pilot randomized double-blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction, 98, 1137-1141.
54. Simpson, D., & Plosker, G. L. (2004). Atomoxetine: A review of its use in adults with attention deficit hyperactivity disorder. Drugs, 64, 205-222.
55. Spealman, R. D. (1995). Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 275, 53-62.
56. Stoops, W. W., Lile, J. A., Glaser, P. E., & Rush, C. R. (2005). Discriminative-stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology, 13, 56-64.
57. Terry, P., Witkin, J. M., & Katz, J. L. (1994). Pharmacological characterization of the novel discriminative-stimulus effects of a low dose of cocaine. Journal of Pharmacology and Experimental Therapeutics, 270, 1041-1048.
58. Thompson, T. (1984). Behavioral mechanisms of drug dependence. In J. E. Barrett (Ed.), Advances in behavioral pharmacology (pp. 1-45). New York: Academic Press.
59. Tidey, J. W., & Bergman, J. (1998). Drug discrimination in methamphetamine-trained monkeys: Agonist and antagonist effects of dopaminergic drugs. Journal of Pharmacology and Experimental Therapeutics, 285, 1163-1174.
60. U.S. Drug Enforcement Administration. (n.d.). Drug scheduling. Retrieved April 26, 2006, from www.dea.gov/pubs/scheduling.html
61. Wee, S., & Woolverton, W. L. (2004). Evaluation of the reinforcing effects of atomoxetine in monkeys: Comparison to methylphenidate and desipramine. Drug and Alcohol Dependence, 75, 271-276.